Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–97.

Article  PubMed  Google Scholar 

Eleftheriadou A, Spallone V, Tahrani AA, Alam U. Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management. Diabetologia. 2024;1–15. https://doi.org/10.1007/s00125-024-06242-0.

Duque A, Mediano MFF, De Lorenzo A, Rodrigues LF Jr. Cardiovascular autonomic neuropathy in diabetes: pathophysiology, clinical assessment and implications. World J Diabetes. 2021;12(6):855–67.

Article  PubMed  PubMed Central  Google Scholar 

Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB prospective complications study (PCS). Diabetes Care. 2008;31(7):1360–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoo JH, Kim JH. Time in range from continuous glucose monitoring: a novel metric for glycemic control. Diabetes Metab J. 2021;45(5):795.

Article  PubMed  PubMed Central  Google Scholar 

Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care 2016, 39(5):686–693.

Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):31–8.

Article  CAS  PubMed  Google Scholar 

Matsutani D, Sakamoto M, Iuchi H, Minato S, Suzuki H, Kayama Y, Takeda N, Horiuchi R, Utsunomiya K. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report. Cardiovasc Diabetol. 2018;17(1):36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galindo RJ, Aleppo G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract. 2020;170:108502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ajjan RA, Battelino T, Cos X, Del Prato S, Philips JC, Meyer L, Seufert J, Seidu S. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nat Rev Endocrinol. 2024;20(7):426–40.

Article  PubMed  Google Scholar 

Tay J, Thompson CH, Brinkworth GD. Glycemic variability: assessing glycemia differently and the implications for dietary management of diabetes. Annu Rev Nutr. 2015;35:389–424.

Article  CAS  PubMed  Google Scholar 

Naaman SH, Mizrak HI, Lind N, Laursen JC, Kufaishi H, Christensen MMB, Ranjan AG, Nørgaard K, Hansen CS. Cardiovascular autonomic neuropathy is associated with increased glucose variability in people with type 1 diabetes. Diabetes Care. 2022;45(10):2461–5.

Article  CAS  PubMed  Google Scholar 

Xu W, Zhu Y, Yang X, Deng H, Yan J, Lin S, Yang H, Chen H, Weng J. Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients. Int J Cardiol. 2016;215:263–8.

Article  PubMed  Google Scholar 

Jun JE, Lee SE, Lee YB, Ahn JY, Kim G, Hur KY, Lee MK, Jin SM, Kim JH. Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes. Diabetes Metab Res Rev. 2019;35(2):e3092.

Article  PubMed  Google Scholar 

Kim MY, Kim G, Park JY, Choi MS, Jun JE, Lee YB, Jin SM, Hur KY, Kim JH. The association between continuous glucose monitoring-derived metrics and cardiovascular autonomic neuropathy in outpatients with type 2 diabetes. Diabetes Technol Ther. 2021;23(6):434–42.

Article  CAS  PubMed  Google Scholar 

Christensen MMB, Hommel EE, Jørgensen ME, Fleischer J, Hansen CS. Glycemic variability and diabetic neuropathy in young adults with type 1 diabetes. Front Endocrinol (Lausanne). 2020;11:644.

Article  PubMed  Google Scholar 

Guo Q, Zang P, Xu S, Song W, Zhang Z, Liu C, Guo Z, Chen J, Lu B, Gu P, Shao J. Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of hba1c in chinese type 2 diabetes. J Diabetes Res. 2020;2020:5817074.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119–33.

Article  PubMed  Google Scholar 

Fleischer J, Lebech Cichosz S, Hoeyem P, Laugesen E, Loegstrup Poulsen P, Sandahl Christiansen J, Tarnow L, Hansen TK. Glycemic variability is associated with reduced cardiac autonomic modulation in women with type 2 diabetes. Diabetes Care. 2015;38(4):682–8.

Article  CAS  PubMed  Google Scholar 

Racca C, Bouman EJ, Van Beers CAJ, Smits MM, van Raalte DH, Serné EH. Association between hypoglycaemic glucose variability and autonomic function in type1 diabetes with impaired hypoglycaemia awareness. Diabetes Res Clin Pract. 2022;189:109964.

Article  CAS  PubMed  Google Scholar 

Chen Y, Jia T, Yan X, Dai L. Blood glucose fluctuations in patients with coronary heart disease and diabetes mellitus correlates with heart rate variability: a retrospective analysis of 210 cases. Niger J Clin Pract. 2020;23(9):1194–200.

Article  CAS  PubMed  Google Scholar 

Fleischer J, Laugesen E, Cichosz SL, Hoeyem P, Dejgaard TF, Poulsen PL, Tarnow L, Hansen TK. Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy. J Diabetes Complications. 2017;31(9):1389–93.

Article  PubMed  Google Scholar 

Gad H, Elgassim E, Mohammed I, Alhaddad AY, Aly H, Cabibihan JJ, Al-Ali A, Sadasivuni KK, Petropoulos IN, Ponirakis G, et al. Cardiovascular autonomic neuropathy is associated with increased glycemic variability driven by hyperglycemia rather than hypoglycemia in patients with diabetes. Diabetes Res Clin Pract. 2023;200:110670.

Article  CAS  PubMed  Google Scholar 

Jaiswal M, McKeon K, Comment N, Henderson J, Swanson S, Plunkett C, Nelson P, Pop-Busui R. Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2014;37(9):2616–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jun JE, Jin SM, Baek J, Oh S, Hur KY, Lee MS, Lee MK, Kim JH. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:70.

Article  PubMed  PubMed Central  Google Scholar 

Klimontov VV, Myakina NE, Tyan NV. Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulin. Springerplus. 2016;5:337.

Article  PubMed  PubMed Central  Google Scholar 

Nyiraty S, Pesei F, Orosz A, Coluzzi S, Vági OE, Lengyel C, Ábrahám G, Frontoni S, Kempler P, Várkonyi T. Cardiovascular autonomic neuropathy and glucose variability in patients with type 1 diabetes: is there an association? Front Endocrinol (Lausanne). 2018;9:174.

Article  PubMed  Google Scholar 

Jia Y, Long D, Yang Y, Wang Q, Wu Q, Zhang Q. Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2024;111757. https://doi.org/10.1016/j.diabres.2024.111757.

Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Glucose variability; does it matter? Endocr Rev. 2010;31(2):171–82.

Article  CAS  PubMed  Google Scholar 

Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644–55.

Article  PubMed